Ophthalmic Product Company Sold in a Kinsella Group-Led Process

📈 Strategic Exit: Ophthalmic Product Company Sold to a Strategic Buyer in a Kinsella Group-Led Process

Our client, a finished-product company in the Ophthalmology space, has been acquired by a strategic buyer in a structured transaction. Kinsella Group served as the exclusive advisor throughout the process, helping our client unlock significant shareholder value by tapping into the larger capabilities and reach of a major industry player.

1️⃣ Built Leadership in Underserved Specialty Areas
Our client developed three primary product portfolios and achieved market leadership positions in each, selling over 115 SKUs across the US, Europe, Asia, and Latin America.

2️⃣ A Competitive, Structured Process
Kinsella Group developed a Teaser, CIM, and valuation model, then reached out to more than 30 potential buyer candidates. After building interest and qualifying the field, Kinsella Group and our client narrowed the pool to the candidates offering the greatest strategic synergies.

3️⃣ Multiple Offers, the Right Fit
Kinsella Group secured offers from three high-quality buyer candidates and guided our client’s ownership through evaluating each. Ultimately, our client selected the acquirer that best matched its long-term vision — one that also offered a strong strategic and cultural fit.

4️⃣ From Term Sheet to Close
Kinsella Group advised our client on deal structure options and supported the transaction through to completion, ensuring a quick and effective process from engagement to close.

🌱 Kinsella Group takeaway
This transaction shows how Kinsella Group’s disciplined, well-run sale process can help lower middle-market companies achieve outsized outcomes. By systematically engaging the right buyer universe, we helped our client realize the full value of the business they built — and positioned the company for its next chapter with a partner equipped to scale it.

This transaction reflects Kinsella Group’s deep expertise advising MedTech and Life Sciences companies through complex transactions. From specialty device manufacturers to broader healthcare technology businesses, our team brings a proven process, sector-specific relationships, and a track record of helping owners maximize value while finding the right long-term partner for their business.

Read more information on this transaction on our Results page here.

In order to provide securities related services, certain principles of Kinsella are registered representatives of Burch and Company, Inc., an unaffiliated FINRA member broker dealer.